MiMedx Group, Inc.
MDXGNASDAQHealthcare● Active
$3.77
+$0.03(+0.67%)
Market Cap$560780677
P/E Ratio—
52W High$7.99
52W Low$3.03
MiMedx Group, Inc. (MDXG) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MDXG · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.42B | $0.35B | $0.32B | $0.27B | $0.24B |
| Cost of Revenue | $0.07B | $0.06B | $0.05B | $0.05B | $0.04B |
| Gross Profit | $0.35B | $0.29B | $0.27B | $0.22B | $0.20B |
| Gross Margin %(computed) | 82.56% | 82.78% | 83.01% | 81.96% | 83.63% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.01B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.28B | $0.23B | $0.23B | $0.23B | $0.21B |
| Operating Income | $0.06B | $0.06B | $0.04B | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | 15.26% | 16.87% | 11.55% | -5.50% | -2.91% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.01B | $0.01B | $0.00B |
| Income Before Tax | $0.07B | $0.06B | $0.03B | ($0.02B) | ($0.01B) |
| Income Tax Expense | $0.02B | $0.02B | ($0.04B) | $0.00B | $0.00B |
| Net Income | $0.05B | $0.04B | $0.07B | ($0.03B) | ($0.01B) |
| Net Margin %(computed) | 11.60% | 12.16% | 20.98% | -11.27% | -5.08% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.33 | $0.29 | $0.48 | $-0.27 | $-0.09 |
| Wtd Avg Shares | 0.15B | 0.15B | 0.12B | 0.11B | 0.11B |
| EBITDA | $0.08B | $0.07B | $0.04B | ($0.01B) | ($0.00B) |
| EBITDA Margin %(computed) | 19.81% | 18.73% | 12.61% | -3.99% | -0.78% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more MiMedx Group, Inc. data
About MiMedx Group, Inc. (MDXG) Income Statement
MiMedx Group, Inc. (MDXG) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MDXG reported revenue of $0.42B, gross profit of $0.35B (gross margin 82.56%), and net income of $0.05B — a net profit margin of 11.60%.
Frequently asked questions
MDXG · 4 questionsMiMedx Group, Inc. (MDXG) reported revenue of $0.42B for 2025, up 20.0% year-over-year.
MDXG revenueMDXG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08